Citations

Citations to this article as recorded by  

• Harnessing Pentameric Scaffold of Cholera Toxin B (CTB) for Design of Subvirion Recombinant Dengue Virus Vaccine
  Jemin Sung, Yucheol Cheong, Young-Seok Kim, Jina Ahn, Myung Hyun Sohn, Sanguine Byun, Baik-Lin Seong
  Vaccines.2024; 12(1): 92.     CrossRef
• Global progress in clinical research on human respiratory syncytial virus vaccines
  Ruofan Peng, Chenghao Chen, Qian Chen, Yuwen Zhang, Renjin Huang, Yanjun Zhang, Jianhua Li
  Frontiers in Microbiology.2024;[Epub]     CrossRef
• Virus-like particles in poultry disease: an approach to effective and safe vaccination
  Abdullahi Abdullahi Raji, Paniz Zarghami Dastjerdi, Abdul Rahman Omar
  Frontiers in Veterinary Science.2024;[Epub]     CrossRef
• Sf9 Cell Metabolism Throughout the Recombinant Baculovirus and Rabies Virus-Like Particles Production in Two Culture Systems
  Luis Giovani Oliveira Guardalini, Jaci Leme, Paulo Eduardo da Silva Cavalcante, Renata Gois de Mello, Thaissa Consoni Bernardino, Simone Gonçalves Silva Jared, Marta Maria Antoniazzi, Renato Mancini Astray, Aldo Tonso, Eutimio Gustavo Fernández Núñez, Sor
  Molecular Biotechnology.2024; 66(2): 354.     CrossRef
• Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview
  Ruth Henríquez, Isabel Muñoz-Barroso
  Heliyon.2024; 10(15): e34927.     CrossRef
• Design and Application of Biosafe Coronavirus Engineering Systems without Virulence
  Guoqiang Wu, Qiaoyu Li, Junbiao Dai, Guobin Mao, Yingxin Ma
  Viruses.2024; 16(5): 659.     CrossRef
• Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter
  Sara Molenda, Agata Sikorska, Anna Florczak, Patryk Lorenc, Hanna Dams-Kozlowska
  Cancers.2023; 15(23): 5647.     CrossRef
• Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery
  Vartika Srivastava, Kripa N. Nand, Aijaz Ahmad, Ravinder Kumar
  Vaccines.2023; 11(2): 479.     CrossRef
• Viral protein-based nanoparticles (part 2): Pharmaceutical applications
  Rocio Mellid-Carballal, Sara Gutierrez-Gutierrez, Carmen Rivas, Marcos Garcia-Fuentes
  European Journal of Pharmaceutical Sciences.2023; 189: 106558.     CrossRef
• Current and emerging pharmacotherapy for respiratory syncytial virus (RSV) infection in infants
  Nicola Principi, Giovanni Autore, Serafina Perrone, Susanna Esposito
  Expert Opinion on Pharmacotherapy.2023; 24(6): 747.     CrossRef
• Viral Nanoparticles‐Mediated Delivery of Therapeutic Cargo
  Saba Zanganeh, Mohammad Doroudian, Zohreh R. Nowzari, Pourya Nasirmoghadas, Javid Sadri Nahand, Shima Sepehrpour, Mohsen Moghoofei
  Advanced Therapeutics.2023;[Epub]     CrossRef
• Emerging Trends and Future Challenges of Nanovaccine Delivery via Nasal Route
  Hitesh Kumar Dewangan, Akash Raghuvanshi, Kamal Shah
  Current Drug Targets.2023; 24(3): 261.     CrossRef
• A Virus-like Particle-Based F4 Enterotoxigenic Escherichia coli Vaccine Is Inhibited by Maternally Derived Antibodies in Piglets but Generates Robust Responses in Sows
  Kara-Lee Aves, Priscila R. Guerra, Ana H. Fresno, Mauro M. S. Saraiva, Eric Cox, Poul J. Bækbo, Morten A. Nielsen, Adam F. Sander, John E. Olsen
  Pathogens.2023; 12(12): 1388.     CrossRef
• Virus-like Particles as Antiviral Vaccine: Mechanism, Design, and Application
  Lei Zhang, Wen Xu, Xi Ma, XiaoJing Sun, JinBo Fan, Yang Wang
  Biotechnology and Bioprocess Engineering.2023; 28(1): 1.     CrossRef
• Rational design of novel fusion rabies glycoproteins displaying a major antigenic site of foot-and-mouth disease virus for vaccine applications
  Ernesto Garay, Diego Fontana, Lautaro Leschiutta, Ricardo Kratje, Claudio Prieto
  Applied Microbiology and Biotechnology.2022; 106(2): 579.     CrossRef
• Engineering Self-Assembling Protein Nanoparticles for Therapeutic Delivery
  Audrey Olshefsky, Christian Richardson, Suzie H. Pun, Neil P. King
  Bioconjugate Chemistry.2022; 33(11): 2018.     CrossRef
• Can Virus-like Particles Be Used as Synergistic Agent in Pest Management?
  Caroline Deshayes, Anne-Sophie Gosselin-Grenet, Mylène Ogliastro, Bruno Lapied, Véronique Apaire-Marchais
  Viruses.2022; 14(5): 943.     CrossRef
• Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases
  Hasnat Tariq, Sannia Batool, Saaim Asif, Mohammad Ali, Bilal Haider Abbasi
  Frontiers in Microbiology.2022;[Epub]     CrossRef
• Development and characterization of monoclonal antibodies against red-spotted grouper nervous necrosis virus and their neutralizing potency in vitro
  Zhiqi Zhang, Jing Xing, Xiaoqian Tang, Xiuzhen Sheng, Heng Chi, Wenbin Zhan
  Aquaculture.2022; 560: 738562.     CrossRef
• Sendai virus particles carrying target virus glycoproteins for antibody induction
  Hiroshi Ishii, Midori Nakamura-Hoshi, Tsugumine Shu, Tetsuro Matano
  Vaccine.2022; 40(16): 2420.     CrossRef
• Emerging Frontiers in Vaccine Development: A Review of Changing Paradigm
  Ishan Ghosh, Mohit D. Gandhi
  Journal of Biosciences and Medicines.2022; 10(07): 123.     CrossRef
• An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
  Alessio Facciolà, Giuseppa Visalli, Antonio Laganà, Angela Di Pietro
  Vaccines.2022; 10(5): 819.     CrossRef
• RNA-assisted self-assembly of monomeric antigens into virus-like particles as a recombinant vaccine platform
  Beom Jeung Hwang, Yohan Jang, Soon Bin Kwon, Ji Eun Yu, Jongkwan Lim, Young Hoon Roh, Baik L. Seong
  Biomaterials.2021; 269: 120650.     CrossRef
• Disulfide Bridging Strategies in Viral and Nonviral Platforms for Nucleic Acid Delivery
  Kingshuk Dutta, Ritam Das, Jewel Medeiros, S. Thayumanavan
  Biochemistry.2021; 60(13): 966.     CrossRef
• Engineering Tobacco Mosaic Virus and Its Virus‐Like‐Particles for Synthesis of Biotemplated Nanomaterials
  Kok Zhi Lee, Vindula Basnayake Pussepitiyalage, Yu‐Hsuan Lee, L. Sue Loesch‐Fries, Michael T. Harris, Shohreh Hemmati, Kevin V. Solomon
  Biotechnology Journal.2021;[Epub]     CrossRef
• Racing to immunity: Journey to a COVID‐19 vaccine and lessons for the future
  Ester Calvo Fernández, Lucie Y. Zhu
  British Journal of Clinical Pharmacology.2021; 87(9): 3408.     CrossRef
• Advanced Nanobiomedical Approaches to Combat Coronavirus Disease of 2019
  Halle Lutz, Kristen D. Popowski, Phuong-Uyen C. Dinh, Ke Cheng
  Advanced NanoBiomed Research.2021;[Epub]     CrossRef
• RNA-dependent assembly of chimeric antigen nanoparticles as an efficient H5N1 pre-pandemic vaccine platform
  Jongkwan Lim, Yucheol Cheong, Young-Seok Kim, Wonil Chae, Beom Jeung Hwang, Jinhee Lee, Yo Han Jang, Young Hoon Roh, Sang-Uk Seo, Baik L. Seong
  Nanomedicine: Nanotechnology, Biology and Medicine.2021; 37: 102438.     CrossRef
• Nano-based approaches in the development of antiviral agents and vaccines
  Yang Li, Yushuo Xiao, Yuchen Chen, Kun Huang
  Life Sciences.2021; 265: 118761.     CrossRef
• Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
  Saghi Nooraei, Howra Bahrulolum, Zakieh Sadat Hoseini, Camellia Katalani, Abbas Hajizade, Andrew J. Easton, Gholamreza Ahmadian
  Journal of Nanobiotechnology.2021;[Epub]     CrossRef
• VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases
  Aline Maria Vasconcelos Queiroz, Johny Wysllas de Freitas Oliveira, Cláudia Jassica Moreno, Diego M. A. Guérin, Marcelo Sousa Silva
  Vaccines.2021; 9(3): 220.     CrossRef
• Nervous Necrosis Virus-like Particle (VLP) Vaccine Stimulates European Sea Bass Innate and Adaptive Immune Responses and Induces Long-Term Protection against Disease
  Sofie Barsøe, Kerstin Skovgaard, Dagoberto Sepúlveda, Ansgar Stratmann, Niccolò Vendramin, Niels Lorenzen
  Pathogens.2021; 10(11): 1477.     CrossRef
• Long-Term Protection and Serologic Response of European Sea Bass Vaccinated with a Betanodavirus Virus-Like Particle Produced in Pichia pastoris
  Sofie Barsøe, Anna Toffan, Francesco Pascoli, Ansgar Stratmann, Tobia Pretto, Andrea Marsella, Mériem Er-Rafik, Niccolò Vendramin, Niels J. Olesen, Dagoberto Sepúlveda, Niels Lorenzen
  Vaccines.2021; 9(5): 447.     CrossRef
• Expression, Purification, and Characterization of Bovine Leukemia Virus-Like Particles Produced in Drosophila S2 Cells
  Natalia Olivero-Deibe, Lorena Tomé-Poderti, Federico Carrión, Sergio Bianchi, Martín Fló, Daniel Prieto, Florencia Rammauro, Andrés Addiego, Natalia Ibañez, Madelón Portela, Rosario Duran, Mabel Berois, Otto Pritsch
  Frontiers in Virology.2021;[Epub]     CrossRef
• Nanotechnology Interventions in the Management of COVID-19: Prevention, Diagnosis and Virus-Like Particle Vaccines
  Acharya Balkrishna, Vedpriya Arya, Akansha Rohela, Ashwani Kumar, Rachna Verma, Dinesh Kumar, Eugenie Nepovimova, Kamil Kuca, Naveen Thakur, Nikesh Thakur, Pankaj Kumar
  Vaccines.2021; 9(10): 1129.     CrossRef
• Baculovirus affinity removal in viral-based bioprocesses
  Mafalda G. Moleirinho, Rita P. Fernandes, Sofia B. Carvalho, Sandra Bezemer, Frank Detmers, Pim Hermans, Ricardo J.S. Silva, Paula M. Alves, Manuel J.T. Carrondo, Cristina Peixoto
  Separation and Purification Technology.2020; 241: 116693.     CrossRef
• Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines
  Naru Zhang, Chaoqun Li, Shibo Jiang, Lanying Du
  Vaccines.2020; 8(3): 481.     CrossRef
• A Flow-Through Chromatographic Strategy for Hepatitis C Virus-Like Particles Purification
  Ricardo J. S. Silva, Mafalda G. Moleirinho, Ana S. Moreira, Alex Xenopoulos, Paula M. Alves, Manuel J. T. Carrondo, Cristina Peixoto
  Processes.2020; 8(1): 85.     CrossRef
• Virus-like particle vaccine displaying Toxoplasma gondii apical membrane antigen 1 induces protection against T. gondii ME49 infection in mice
  Min-Ju Kim, Su-Hwa Lee, Hae-Ji Kang, Ki-Back Chu, Hyunwoo Park, Hui Jin, Eun-Kyung Moon, Sung Soo Kim, Fu-Shi Quan
  Microbial Pathogenesis.2020; 142: 104090.     CrossRef
• Bacterial Production of Barley Stripe Mosaic Virus Biotemplates for Palladium Nanoparticle Growth
  Yu-Hsuan Lee, Kok Zhi Lee, Rachel G. Susler, Corren A. Scott, Longfei Wang, L. Sue Loesch-Fries, Michael T. Harris, Kevin V. Solomon
  ACS Applied Nano Materials.2020; 3(12): 12080.     CrossRef
• Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
  Carlotta Biagi, Arianna Dondi, Sara Scarpini, Alessandro Rocca, Silvia Vandini, Giulia Poletti, Marcello Lanari
  Vaccines.2020; 8(4): 672.     CrossRef
• Virus-like particle-display of the enterotoxigenic Escherichia coli heat-stable toxoid STh-A14T elicits neutralizing antibodies in mice
  Morten L. Govasli, Yuleima Diaz, Pål Puntervoll
  Vaccine.2019; 37(43): 6405.     CrossRef
• Protein and Peptide Biomaterials for Engineered Subunit Vaccines and Immunotherapeutic Applications
  Alexandra N. Tsoras, Julie A. Champion
  Annual Review of Chemical and Biomolecular Engineering.2019; 10(1): 337.     CrossRef
• Capsid containing virus like particle vaccine against Zika virus made from a stable cell line
  Himanshu Garg, Tugba Mehmetoglu-Gurbuz, Gregory M. Ruddy, Anjali Joshi
  Vaccine.2019; 37(48): 7123.     CrossRef
• Incorporation of CD40 ligand enhances the immunogenicity of tumor‑associated calcium signal transducer 2 virus‑like particles against lung cancer
  Wang Xi, Dong Ke, Long Min, Wang Lin, Zuo Jiahui, Lin Fang, Gao Zhaowei, Zhang Zhe, Chen Xi, Zhang Huizhong
  International Journal of Molecular Medicine.2018;[Epub]     CrossRef
• Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles
  Young-Seok Kim, Ahyun Son, Jihoon Kim, Soon Bin Kwon, Myung Hee Kim, Paul Kim, Jieun Kim, Young Ho Byun, Jemin Sung, Jinhee Lee, Ji Eun Yu, Chan Park, Yeon-Sook Kim, Nam-Hyuk Cho, Jun Chang, Baik L. Seong
  Frontiers in Immunology.2018;[Epub]     CrossRef
• Nanoparticle vaccines against viral infections
  Fernando B. Sulczewski, Raquel B. Liszbinski, Pedro R. T. Romão, Luiz Carlos Rodrigues Junior
  Archives of Virology.2018; 163(9): 2313.     CrossRef
• Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71
  Xi Wang, Ke Dong, Min Long, Fang Lin, Zhaowei Gao, Lin Wang, Zhe Zhang, Xi Chen, Ying Dai, Huiping Wang, Huizhong Zhang
  Archives of Virology.2018; 163(7): 1851.     CrossRef
• Questions of bioethics and biosafety in the problem of biotechnology and use of vaccine for prevention of human infectious diseases
  V. Zadorozhna, N. Vynnyk
  Bulletin "Veterinary biotechnology".2018; 32(1): 459.     CrossRef
• MultiBac: from protein complex structures to synthetic viral nanosystems
  Martin Pelosse, Hannah Crocker, Barbara Gorda, Paul Lemaire, Jens Rauch, Imre Berger
  BMC Biology.2017;[Epub]     CrossRef
• Green Tea Catechin-Inactivated Viral Vaccine Platform
  Yun H. Lee, Yo H. Jang, Young H. Byun, Yucheol Cheong, Paul Kim, Young J. Lee, Yoon J. Lee, Je M. Sung, Ahyun Son, Hye M. Lee, Jinhee Lee, Seung W. Yang, Jae-Min Song, Baik L. Seong
  Frontiers in Microbiology.2017;[Epub]     CrossRef
• Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus
  Himanshu Garg, Melina Sedano, Gabrielle Plata, Erin B. Punke, Anjali Joshi, Michael S. Diamond
  Journal of Virology.2017;[Epub]     CrossRef